News

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingAs the global vaccine community gathers for the World Vaccine Congress in Washington, D.C., from April 1-4, Genoskin is excited to announce its participation in this prestigious event. Set to take place at the heart of the nation's capital, the congress is a cornerstone event for vaccine professionals worldwide,Read more

Top-level science through the eyes of an expert.The seventh Webinar. The seventh webinar in the Naked Immunology series is now scheduled on April 8, 2024 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Marcus Maurer, MD, Professor of Dermatology and Allergy, Co‐DirectorRead more

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, hasRead more

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: GlobalRead more

Genoskin at SOT 63rd Annual Meeting and ToxExpoPioneering Human Skin Models for Advanced Toxicology ResearchAs the world of toxicology convened for the Society of Toxicology 63rd Annual Meeting and ToxExpo, Genoskin was excited to announce its participation in this event, which took place from March 10-14 at the Salt Palace Convention Center in Salt Lake City. This year, Genoskin showcasedRead more

Understanding Local Tolerancein Drug DevelopmentIn the ever-evolving field of drug development, ensuring the safety and efficacy of new therapeutic agents is paramount. A crucial aspect of this safety evaluation is the assessment of cytotoxicity – the potential of substances to harm or destroy cells. Particularly in the realm of skin cytotoxicity, the concept of Local Tolerance, especially in the contextRead more